rs755191122

Variant summary

Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_003919.3(SGCE):ā€‹c.5A>Cā€‹(p.Gln2Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000937 in 1,600,992 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.000020 ( 0 hom., cov: 31)
Exomes š‘“: 0.0000083 ( 0 hom. )

Consequence

SGCE
NM_003919.3 missense

Scores

6
13

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.0260
Variant links:
Genes affected
SGCE (HGNC:10808): (sarcoglycan epsilon) This gene encodes the epsilon member of the sarcoglycan family. Sarcoglycans are transmembrane proteins that are components of the dystrophin-glycoprotein complex, which link the actin cytoskeleton to the extracellular matrix. Unlike other family members which are predominantly expressed in striated muscle, the epsilon sarcoglycan is more broadly expressed. Mutations in this gene are associated with myoclonus-dystonia syndrome. This gene is imprinted, with preferential expression from the paternal allele. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. A pseudogene associated with this gene is located on chromosome 2. [provided by RefSeq, Oct 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.22191033).
BS2
High AC in GnomAdExome4 at 12 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SGCENM_003919.3 linkuse as main transcriptc.5A>C p.Gln2Pro missense_variant 1/11 ENST00000648936.2 NP_003910.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SGCEENST00000648936.2 linkuse as main transcriptc.5A>C p.Gln2Pro missense_variant 1/11 NM_003919.3 ENSP00000497130 A1O43556-1

Frequencies

GnomAD3 genomes
AF:
0.0000197
AC:
3
AN:
152094
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.00000400
AC:
1
AN:
249918
Hom.:
0
AF XY:
0.00000739
AC XY:
1
AN XY:
135404
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000886
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000828
AC:
12
AN:
1448898
Hom.:
0
Cov.:
29
AF XY:
0.0000125
AC XY:
9
AN XY:
721814
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000109
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000197
AC:
3
AN:
152094
Hom.:
0
Cov.:
31
AF XY:
0.0000269
AC XY:
2
AN XY:
74290
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000441
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000434
Hom.:
0
Bravo
AF:
0.0000151
ExAC
AF:
0.00000824
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Myoclonic dystonia 11 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpMay 05, 2023In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The proline amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. ClinVar contains an entry for this variant (Variation ID: 566714). This variant has not been reported in the literature in individuals affected with SGCE-related conditions. This variant is present in population databases (rs755191122, gnomAD 0.003%). This sequence change replaces glutamine, which is neutral and polar, with proline, which is neutral and non-polar, at codon 2 of the SGCE protein (p.Gln2Pro). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.066
BayesDel_addAF
Uncertain
0.069
T
BayesDel_noAF
Benign
-0.12
CADD
Benign
15
DANN
Benign
0.79
DEOGEN2
Benign
0.0054
.;T;T;.;T;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;T;.;.;.
Eigen
Benign
-0.75
Eigen_PC
Benign
-0.67
FATHMM_MKL
Benign
0.078
N
LIST_S2
Uncertain
0.89
D;D;.;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;.;D;D;D;D;D;D;D;D
M_CAP
Uncertain
0.15
D
MetaRNN
Benign
0.22
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Uncertain
0.42
D
MutationAssessor
Benign
0.0
.;.;N;.;N;.;N;N;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.
MutationTaster
Benign
0.99
N;N;N;N;N;N
PrimateAI
Uncertain
0.69
T
PROVEAN
Benign
-0.060
.;N;.;.;N;.;.;N;N;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;N;.;.;N;.;.;.
REVEL
Uncertain
0.36
Sift
Benign
0.11
.;T;.;.;T;.;.;T;T;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;T;.;.;T;.;.;.
Sift4G
Benign
0.083
.;T;.;.;T;.;.;T;T;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;T;.;.;T;.;.;.
Polyphen
0.46, 0.0
.;.;P;.;P;.;.;.;P;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;B;.;.;.
Vest4
0.38, 0.35, 0.47, 0.43, 0.41, 0.40
MutPred
0.34
Gain of catalytic residue at Q2 (P = 0.0022);Gain of catalytic residue at Q2 (P = 0.0022);Gain of catalytic residue at Q2 (P = 0.0022);Gain of catalytic residue at Q2 (P = 0.0022);Gain of catalytic residue at Q2 (P = 0.0022);Gain of catalytic residue at Q2 (P = 0.0022);Gain of catalytic residue at Q2 (P = 0.0022);Gain of catalytic residue at Q2 (P = 0.0022);Gain of catalytic residue at Q2 (P = 0.0022);Gain of catalytic residue at Q2 (P = 0.0022);Gain of catalytic residue at Q2 (P = 0.0022);Gain of catalytic residue at Q2 (P = 0.0022);Gain of catalytic residue at Q2 (P = 0.0022);Gain of catalytic residue at Q2 (P = 0.0022);Gain of catalytic residue at Q2 (P = 0.0022);Gain of catalytic residue at Q2 (P = 0.0022);Gain of catalytic residue at Q2 (P = 0.0022);Gain of catalytic residue at Q2 (P = 0.0022);Gain of catalytic residue at Q2 (P = 0.0022);Gain of catalytic residue at Q2 (P = 0.0022);Gain of catalytic residue at Q2 (P = 0.0022);Gain of catalytic residue at Q2 (P = 0.0022);Gain of catalytic residue at Q2 (P = 0.0022);Gain of catalytic residue at Q2 (P = 0.0022);Gain of catalytic residue at Q2 (P = 0.0022);Gain of catalytic residue at Q2 (P = 0.0022);Gain of catalytic residue at Q2 (P = 0.0022);Gain of catalytic residue at Q2 (P = 0.0022);Gain of catalytic residue at Q2 (P = 0.0022);Gain of catalytic residue at Q2 (P = 0.0022);Gain of catalytic residue at Q2 (P = 0.0022);Gain of catalytic residue at Q2 (P = 0.0022);Gain of catalytic residue at Q2 (P = 0.0022);
MVP
0.78
MPC
0.42
ClinPred
0.040
T
GERP RS
-1.3
Varity_R
0.14
gMVP
0.25

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs755191122; hg19: chr7-94285406; API